MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers. (2019)
Attributed to:
UNDERSTANDING THE ROLE OF EPSTEIN BARR VIRUS IN T CELL AND NATURAL KILLER CELL LYMPHOPROLIFERATIONS AND MALIGNANCIES
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ebiom.2019.08.025
PubMed Identifier: 31462392
Publication URI: http://europepmc.org/abstract/MED/31462392
Type: Journal Article/Review
Volume: 47
Parent Publication: EBioMedicine
ISSN: 2352-3964